Healthcare Realty: Insights on Dividend and Recent Developments Before Aug 14, 2025
Generated by AI AgentAinvest Dividend Digest
Sunday, Aug 10, 2025 10:02 pm ET1min read
HR--
Aime Summary
Aime SummaryHealthcare Realty (HR) has announced its latest dividend details, with an ex-dividend date set for Aug 14, 2025, and a payout date on Aug 28, 2025. The dividend per share stands at $0.240, significantly lower than the average of the last ten dividends, which was $0.350. Previously, HRHR-- distributed $0.310 per share on May 23, 2025. The company consistently adopts cash dividends as its dividend type.
Recently, Healthcare Realty TrustHR-- has been actively repositioning itself through strategic measures such as capital discipline, asset optimization, and balance sheet restructuring. These efforts are aimed at unlocking value for shareholders. Analysts have highlighted a cautious hold rating on HR, noting its positive growth prospects amidst strategic challenges. The company reported a robust Q2 normalized FFO of $0.410, surpassing consensus estimates of $0.400, with revenues slightly below expectations at $297.500 million. Furthermore, HR has raised its FY25 normalized FFO view, indicating a promising outlook.
Over the past week, Healthcare RealtyHR-- Trust has seen significant developments that could impact its operations and market performance. Recently, the company announced a new credit facility agreement on Jul 31, 2025, aiming to strengthen its financial position. Additionally, HR's recent earnings call highlighted robust growth and strategic challenges, contributing to a mixed outlook. The stock price target was recently adjusted from $18 to $17 by analysts, reflecting the current market sentiment and financial health of the company.
In conclusion, Healthcare Realty Trust is navigating through a period of strategic transformation and financial adjustments. Investors interested in securing the upcoming dividend should note that Aug 14, 2025, is the last day to purchase HR's stock to be eligible for this dividend distribution. Purchases made after this date will not qualify for the current dividend payout.
Recently, Healthcare Realty TrustHR-- has been actively repositioning itself through strategic measures such as capital discipline, asset optimization, and balance sheet restructuring. These efforts are aimed at unlocking value for shareholders. Analysts have highlighted a cautious hold rating on HR, noting its positive growth prospects amidst strategic challenges. The company reported a robust Q2 normalized FFO of $0.410, surpassing consensus estimates of $0.400, with revenues slightly below expectations at $297.500 million. Furthermore, HR has raised its FY25 normalized FFO view, indicating a promising outlook.
Over the past week, Healthcare RealtyHR-- Trust has seen significant developments that could impact its operations and market performance. Recently, the company announced a new credit facility agreement on Jul 31, 2025, aiming to strengthen its financial position. Additionally, HR's recent earnings call highlighted robust growth and strategic challenges, contributing to a mixed outlook. The stock price target was recently adjusted from $18 to $17 by analysts, reflecting the current market sentiment and financial health of the company.
In conclusion, Healthcare Realty Trust is navigating through a period of strategic transformation and financial adjustments. Investors interested in securing the upcoming dividend should note that Aug 14, 2025, is the last day to purchase HR's stock to be eligible for this dividend distribution. Purchases made after this date will not qualify for the current dividend payout.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet